sever
acut
respiratori
syndrom
sar
acut
infecti
diseas
spread
mainli
via
respiratori
rout
distinct
coronaviru
sarscov
identifi
aetiolog
agent
sar
recent
metallopeptidas
name
angiotensinconvert
enzym
identifi
function
receptor
sarscov
although
mrna
known
present
virtual
organ
protein
express
larg
unknown
sinc
identifi
possibl
rout
infect
major
implic
understand
pathogenesi
futur
treatment
strategi
sar
present
studi
investig
local
protein
variou
human
organ
oral
nasal
mucosa
nasopharynx
lung
stomach
small
intestin
colon
skin
lymph
node
thymu
bone
marrow
spleen
liver
kidney
brain
remark
find
surfac
express
protein
lung
alveolar
epitheli
cell
enterocyt
small
intestin
furthermor
present
arteri
venou
endotheli
cell
arteri
smooth
muscl
cell
organ
studi
conclus
abundantli
present
human
epithelia
lung
small
intestin
might
provid
possibl
rout
entri
sarscov
epitheli
express
togeth
presenc
vascular
endothelium
also
provid
first
step
understand
pathogenesi
main
sar
diseas
manifest
sever
acut
respiratori
syndrom
sar
acut
infecti
diseas
spread
mainli
via
respiratori
rout
recent
distinct
coronaviru
sarscov
identifi
aetiolog
agent
sar
spike
protein
rna
viru
associ
cellular
receptor
sensit
cell
mediat
infect
target
cell
viral
replic
begin
cytoplasm
main
target
sarscov
lung
immun
organ
system
small
vessel
result
system
vascul
decreas
immun
function
respiratori
distress
caus
extens
pulmonari
consolid
diffus
alveolar
damag
hyalin
membran
format
latter
caus
death
infect
individu
recent
li
et
al
identifi
metallopeptidas
name
angiotensinconvert
enzym
isol
sarscovpermiss
cell
bind
effect
domain
sarscov
protein
cell
form
multinucl
syncytia
cell
express
protein
viru
shown
replic
effect
mocktransfect
cell
antibodi
antibodi
block
viral
replic
cell
data
indic
convincingli
function
receptor
sarscov
although
realtim
pcr
reveal
mrna
express
present
human
tissu
protein
express
thu
far
identifi
heart
kidney
testi
sinc
identifi
possibl
rout
infect
major
implic
understand
pathogenesi
futur
treatment
option
sar
investig
immunoloc
protein
variou
human
organ
procedur
use
anonym
tissu
perform
accord
recent
nation
ethic
guidelin
human
tissu
differ
organ
obtain
patient
undergo
biopsi
procedur
diagnost
purpos
surgeri
variou
reason
predominantli
treatment
cancer
addit
tissu
obtain
unus
donor
organ
organ
unus
technic
reason
often
case
unilater
transplant
lack
adequ
acceptor
lung
extens
specif
diagnosi
given
lung
small
intestin
see
brain
tissu
obtain
autopsi
tissu
chosen
repres
organ
system
sar
viru
detect
human
experiment
infect
macaqu
routin
morpholog
evalu
haematoxylin
eosinstain
section
qualifi
pathologist
tissu
use
character
nondiseas
tissu
investig
differ
subject
lung
cancer
n
unus
donor
lung
n
alpha
antitrypsin
defici
n
skin
n
oral
mucosa
n
nasal
mucosa
n
nasopharynx
n
gastric
cardia
corpu
n
differ
part
small
intestin
duodenum
cancer
n
ulcer
n
jejunum
chronic
inflamm
n
atresia
n
cancer
n
resect
ileostoma
n
ileum
resect
ileostoma
n
chronic
inflamm
n
metastat
cancer
n
primari
cancer
n
hirschprung
diseas
n
angiodysplasia
n
colon
n
spleen
n
thymu
n
lymph
node
n
bone
marrow
n
liver
n
kidney
n
brain
n
lung
type
ii
alveolar
epitheli
cell
line
fibrot
lung
tissu
patient
n
usual
interstiti
pneumonia
use
confirm
find
type
ii
pneumocyt
tissu
dewax
rehydr
subject
heatinduc
antigen
retriev
overnight
incub
trishcl
buffer
ph
c
endogen
peroxidas
block
h
phosphatebuff
salin
pb
ph
min
cytospin
prepar
cell
fix
pbsbuffer
paraformaldehyd
c
min
subsequ
dri
stain
polyclon
rabbit
antiserum
millenium
pharmaceut
inc
cambridg
usa
dilut
pb
supplement
bovin
serum
albumin
use
concentr
h
room
temperatur
antibodi
bind
detect
use
sequenti
incub
peroxidaselabel
goat
antirabbit
peroxidaselabel
rabbit
antigoat
antibodi
garporagpo
dako
glostrup
denmark
human
ab
serum
ad
secondari
antibodi
peroxidas
activ
develop
use
diaminobenzidin
tetrachlorid
dab
min
counterstain
perform
use
mayer
haematoxylin
three
type
control
test
perform
determin
specif
antibodi
first
control
section
incub
antibodi
solut
preincub
synthet
peptid
antibodi
rais
peptid
sequenc
ntniteenvqnmnnagdkw
aa
pepscan
system
bv
lelystad
netherland
second
section
incub
unrel
rabbit
polyclon
antibodi
antialpha
inhibitor
antinitrotyrosin
third
section
incub
pb
without
primari
antibodi
control
section
reveal
stain
figur
qualifi
pathologist
analys
stain
structur
posit
mean
age
patient
n
year
maletofemal
ratio
stain
pattern
consist
type
tissu
regardless
patholog
condit
organ
diseas
statu
patient
first
remark
find
present
endotheli
cell
small
larg
arteri
vein
tissu
studi
moreov
arteri
smooth
muscl
cell
consist
posit
posit
stain
also
note
myofibroblast
membran
fat
cell
variou
organ
furthermor
found
specif
site
organ
describ
mark
immunostain
found
type
type
ii
alveolar
epitheli
cell
normal
lung
figur
find
confirm
express
lung
type
ii
alveolar
epitheli
cell
line
figur
lung
fibrot
chang
reveal
abund
stain
type
ii
epitheli
cell
figur
cytoplasm
bronchial
epitheli
cell
also
show
weak
posit
stain
nasal
oral
mucosa
nasopharynx
found
express
basal
layer
nonkeratin
squamou
epithelium
figur
addit
local
smooth
muscl
cell
endothelium
vessel
stomach
small
intestin
colon
found
smooth
muscl
cell
musculari
mucosa
musculari
propria
figur
remark
abundantli
present
enterocyt
part
small
intestin
includ
duodenum
jejunum
ileum
enterocyt
colon
stain
enterocyt
confin
brush
border
figur
skin
present
basal
cell
layer
epidermi
extend
basal
cell
layer
hair
follicl
figur
smooth
muscl
cell
surround
sebac
gland
also
posit
weak
cytoplasm
stain
observ
sebac
gland
cell
strong
granular
stain
pattern
seen
cell
eccrin
gland
figur
consist
find
organ
brain
reveal
endotheli
smooth
muscl
cell
stain
figur
despit
clear
endotheli
stain
mani
small
vessel
endotheli
line
sinusoid
liver
neg
surfac
stain
bile
duct
occasion
observ
kupffer
cell
hepatocyt
neg
figur
spleen
thymu
lymph
node
bone
marrow
cell
immun
system
b
larger
magnif
submucosa
c
strong
stain
present
vascular
endothelium
arrow
vascular
smooth
muscl
cell
arrowhead
larger
magnif
villi
abund
stain
seen
brush
border
enterocyt
arrow
colon
e
stain
present
endothelium
vascular
smooth
muscl
cell
blood
vessel
arrowhead
muscular
layer
control
section
stain
presenc
synthet
peptid
show
stain
small
intestin
ileum
f
lymphocyt
macrophag
consist
neg
figur
lymph
node
note
posit
stain
sinu
endotheli
cell
granular
stain
pattern
kidney
weak
glomerular
viscer
stain
observ
wherea
pariet
epitheli
cell
moder
posit
despit
clear
endotheli
stain
vessel
mesangium
glomerular
endothelium
neg
abund
stain
seen
brush
border
proxim
tubular
cell
wherea
cytoplasm
cell
weakli
posit
epitheli
cell
distal
tubul
collect
duct
show
weak
cytoplasm
stain
figur
present
paper
report
immunoloc
angiotensinconvert
enzym
function
receptor
sarscov
human
tissu
remark
find
surfac
express
protein
lung
alveolar
epitheli
cell
enterocyt
small
intestin
ie
cell
contact
extern
environ
furthermor
present
arteri
venou
endotheli
cell
arteri
smooth
muscl
cell
organ
studi
data
consist
previou
find
low
level
mrna
found
mani
tissu
mrna
highli
express
renal
cardiovascular
gastrointestin
tissu
physiolog
role
tissu
elucid
although
thought
essenti
regul
cardiac
function
blood
pressur
control
possibl
act
natur
counterpart
recent
identifi
function
receptor
sarscov
li
et
al
show
immunoprecipit
domain
sarscov
viru
promot
viral
replic
demonstr
express
human
organ
potenti
identifi
possibl
rout
infect
sarscov
possibl
rout
spread
replic
throughout
bodi
sar
mainli
lower
respiratori
tract
diseas
caus
pulmonari
lesion
respiratori
distress
furthermor
sarscov
spread
via
respiratori
tract
recent
studi
autopsi
seri
use
viral
isol
cultur
techniqu
situ
hybrid
show
sarscov
present
pneumocyt
transmiss
electron
microscopi
reveal
presenc
coronaviruslik
particl
viral
inclus
bodi
pneumocyt
found
type
type
ii
pneumocyt
markedli
posit
bronchial
epitheli
cell
show
weak
stain
type
ii
alveolar
epitheli
cell
line
confirm
presenc
protein
type
ii
pneumocyt
data
combin
fact
function
receptor
sarscov
indic
alveolar
pneumocyt
lung
possibl
site
entranc
sarscov
furthermor
express
pattern
provid
possibl
explan
patholog
lung
manifest
rapid
progress
initi
viral
entranc
may
caus
cytopatholog
chang
epitheli
alveolocapillari
interfac
initi
result
induct
type
ii
alveolar
cell
first
attempt
repair
sar
abund
express
type
ii
alveolar
cell
may
caus
base
rapid
upper
respiratori
tract
symptom
occur
minor
sar
patient
sarscov
rna
detect
nasopharyng
aspir
howev
tissu
upper
respiratori
tract
oral
nasal
mucosa
nasopharynx
show
express
surfac
epitheli
cell
suggest
tissu
primari
site
entranc
sarscov
upper
respiratori
tract
symptom
explain
find
patient
sar
might
suscept
secondari
infect
moreov
sarscov
rna
detect
nasopharyng
aspir
might
deriv
infect
lower
respiratori
tract
extrapulmonari
manifest
sarscov
infect
gastrointestin
symptom
report
includ
wateri
diarrhoea
use
situ
hybrid
et
al
found
sarscov
surfac
small
intestin
enterocyt
activ
viral
replic
enterocyt
small
intestin
report
leung
et
al
sarscov
rna
detect
patient
stool
sampl
shown
protein
abundantli
express
brush
border
enterocyt
part
small
intestin
includ
duodenum
jejunum
ileum
surprisingli
organ
digest
tract
stomach
colon
show
brush
border
stain
presenc
function
receptor
sarscov
presenc
sarscov
enterocyt
small
intestin
combin
fact
viru
present
patient
stool
sampl
consist
possibl
faecoor
transmiss
addit
pulmonari
gastrointestin
problem
sarscov
infect
also
caus
massiv
necrosi
spleen
lymph
node
furthermor
patient
develop
lymphopaenia
analog
respiratori
syncyti
viru
diseas
measl
sepsi
ascrib
increas
apoptosi
lymphocyt
consist
absenc
immun
cell
haematolymphoid
organ
suggest
direct
viral
infect
unlik
caus
manifest
patholog
chang
seen
organ
probabl
relat
system
effect
abnorm
immun
reaction
toward
viru
sarscovrel
manifest
includ
system
vascul
apoptosi
swell
endotheli
cell
inflamm
variou
organ
heart
kidney
liver
adren
gland
abund
express
endothelia
smooth
muscl
cell
virtual
organ
suggest
sarscov
present
circul
spread
easili
bodi
absenc
howev
sarscov
organ
shown
situ
hybrid
studi
varianc
assumpt
vascular
abnorm
inflammatori
chang
variou
organ
might
therefor
relat
system
toxic
effect
immun
reaction
elicit
sarscov
infect
remark
organ
becom
virusposit
despit
presenc
endothelia
organ
sarscov
blood
plasma
infect
individu
may
impli
analog
hiv
infect
current
gener
model
viral
entri
requir
bind
viral
envelop
cell
surfac
receptor
also
chemokin
coreceptor
bba
sarscov
also
need
presenc
coreceptor
cellular
entri
futur
studi
elucid
whether
sarscov
bind
coreceptor
addit
might
involv
specif
infect
lung
small
intestin
conclus
abundantli
present
human
epithelia
lung
small
intestin
might
provid
possibl
rout
entri
sarscov
epitheli
express
togeth
presenc
vascular
endothelium
also
provid
first
step
understand
pathogenesi
main
sar
diseas
manifest
particular
lung
whether
abund
express
vascular
system
may
also
serv
rout
spread
replic
investig
function
studi
appli
blockad
protein
